Press Releases Press Releases Year None202120202019201820172016201520142013201120102009200820072005 November 9, 2021 Intra-Cellular Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update PDF Version November 2, 2021 Intra-Cellular Therapies to Host Third Quarter 2021 Financial Results Conference Call and Webcast PDF Version October 18, 2021 Intra-Cellular Therapies Announces Amended Start Time to Virtual Event on Wednesday, October 20 PDF Version October 8, 2021 Intra-Cellular Therapies to Host a Virtual Event to Feature Highlights of Several of its Development Programs PDF Version September 27, 2021 Intra-Cellular Therapies Announces Publication of Lumateperone Pivotal Phase 3 Study in Bipolar Depression in The American Journal of Psychiatry PDF Version September 22, 2021 Intra-Cellular Therapies to Present at the 2021 Cantor Virtual Global Healthcare Conference PDF Version September 20, 2021 Intra-Cellular Therapies Announces Publications Highlighting Beneficial Effects of Phosphodiesterase Type I Inhibition with Lenrispodun (ITI-214) on Cardiovascular Function in Patients with Heart Failure and in Models of Accelerated Aging PDF Version August 10, 2021 Intra-Cellular Therapies to Present at the Canaccord Genuity 41st Annual Growth Conference PDF Version August 9, 2021 Intra-Cellular Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update PDF Version August 2, 2021 Intra-Cellular Therapies to Host Second Quarter 2021 Financial Results Conference Call and Webcast PDF Version Pagination Current page 1 Page 2 Page 3 Next page next › Last page last »
November 9, 2021 Intra-Cellular Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update PDF Version
November 2, 2021 Intra-Cellular Therapies to Host Third Quarter 2021 Financial Results Conference Call and Webcast PDF Version
October 18, 2021 Intra-Cellular Therapies Announces Amended Start Time to Virtual Event on Wednesday, October 20 PDF Version
October 8, 2021 Intra-Cellular Therapies to Host a Virtual Event to Feature Highlights of Several of its Development Programs PDF Version
September 27, 2021 Intra-Cellular Therapies Announces Publication of Lumateperone Pivotal Phase 3 Study in Bipolar Depression in The American Journal of Psychiatry PDF Version
September 22, 2021 Intra-Cellular Therapies to Present at the 2021 Cantor Virtual Global Healthcare Conference PDF Version
September 20, 2021 Intra-Cellular Therapies Announces Publications Highlighting Beneficial Effects of Phosphodiesterase Type I Inhibition with Lenrispodun (ITI-214) on Cardiovascular Function in Patients with Heart Failure and in Models of Accelerated Aging PDF Version
August 10, 2021 Intra-Cellular Therapies to Present at the Canaccord Genuity 41st Annual Growth Conference PDF Version
August 9, 2021 Intra-Cellular Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update PDF Version
August 2, 2021 Intra-Cellular Therapies to Host Second Quarter 2021 Financial Results Conference Call and Webcast PDF Version
